Skip to main content
logo
bioMérieux S.A. (BMXMF)
OTCMKTS · Delayed Price · Currency is USD
112.57
+1.47 (1.32%)
At close: Feb 6, 2026

bioMérieux Revenue

bioMérieux had revenue of 2.04B EUR in the half year ending June 30, 2025, with 15.46% growth. This brings the company's revenue in the last twelve months to 4.12B, up 8.28% year-over-year. In the year 2024, bioMérieux had annual revenue of 3.98B with 8.31% growth.

Revenue (ttm)
4.12B EUR
Revenue Growth
+8.28%
P/S Ratio
2.69
Revenue / Employee
279.37K EUR
Employees
14,754
Market Cap
13.02B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243.98B305.20M8.31%
Dec 31, 20233.67B85.60M2.38%
Dec 31, 20223.59B212.90M6.31%
Dec 31, 20213.38B258.00M8.27%
Dec 31, 20203.12B443.40M16.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Global Cord Blood196.10M
Centogene53.65M
Bioqual46.54M
Interpace Biosciences41.92M
Psychemedics19.69M
China New Energy Group Company12.51M
Aspira Women's Health9.34M
Longduoduo Company4.15M
Revenue Rankings

bioMérieux News

More News